Moreover we found point mutations in TP53, IDH2, KRAS and NRAS further underpinning a genetic relation between BPDCN and myeloid malignancies, including acute myeloid leukemia and myelodysplastic syndrome. Here, TP53 is linked to acute myeloid leukemia.